LNKing eosinophilia and atherothrombosis No … ← LNKing eosinophilia and atherothrombosis Mannes M, Dopler A, Zolk O, et al. Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity. Blood. 2021;137(4):443-455 →